Cargando…

Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax

The S184 residue of Bax is the target of several protein kinases regulating cell fate, including AKT. It is well-established that, in cellulo, the substitution of S184 by a non-phosphorylatable residue stimulates both the mitochondrial localization of Bax, cytochrome c release, and apoptosis. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonyan, Lilit, Gonin, Mathilde, Hanks, James, Friedlein, Jordan, Dutrec, Kevin, Arokium, Hubert, Rouchidane Eyitayo, Akandé, Doudy, Toukounou Megann, Chaignepain, Stéphane, Manon, Stéphen, Dejean, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892840/
https://www.ncbi.nlm.nih.gov/pubmed/36741728
http://dx.doi.org/10.3389/fonc.2022.1068994
_version_ 1784881396995588096
author Simonyan, Lilit
Gonin, Mathilde
Hanks, James
Friedlein, Jordan
Dutrec, Kevin
Arokium, Hubert
Rouchidane Eyitayo, Akandé
Doudy, Toukounou Megann
Chaignepain, Stéphane
Manon, Stéphen
Dejean, Laurent
author_facet Simonyan, Lilit
Gonin, Mathilde
Hanks, James
Friedlein, Jordan
Dutrec, Kevin
Arokium, Hubert
Rouchidane Eyitayo, Akandé
Doudy, Toukounou Megann
Chaignepain, Stéphane
Manon, Stéphen
Dejean, Laurent
author_sort Simonyan, Lilit
collection PubMed
description The S184 residue of Bax is the target of several protein kinases regulating cell fate, including AKT. It is well-established that, in cellulo, the substitution of S184 by a non-phosphorylatable residue stimulates both the mitochondrial localization of Bax, cytochrome c release, and apoptosis. However, in in vitro experiments, substituted mutants did not exhibit any increase in their binding capacity to isolated mitochondria or liposomes. Despite exhibiting a significant increase of the 6A7 epitope exposure, substituted mutants remain limited in their ability to form large oligomers, suggesting that they high capacity to promote apoptosis in cells was more related to a high content than to an increased ability to form large pores in the outer mitochondrial membranes.
format Online
Article
Text
id pubmed-9892840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98928402023-02-03 Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax Simonyan, Lilit Gonin, Mathilde Hanks, James Friedlein, Jordan Dutrec, Kevin Arokium, Hubert Rouchidane Eyitayo, Akandé Doudy, Toukounou Megann Chaignepain, Stéphane Manon, Stéphen Dejean, Laurent Front Oncol Oncology The S184 residue of Bax is the target of several protein kinases regulating cell fate, including AKT. It is well-established that, in cellulo, the substitution of S184 by a non-phosphorylatable residue stimulates both the mitochondrial localization of Bax, cytochrome c release, and apoptosis. However, in in vitro experiments, substituted mutants did not exhibit any increase in their binding capacity to isolated mitochondria or liposomes. Despite exhibiting a significant increase of the 6A7 epitope exposure, substituted mutants remain limited in their ability to form large oligomers, suggesting that they high capacity to promote apoptosis in cells was more related to a high content than to an increased ability to form large pores in the outer mitochondrial membranes. Frontiers Media S.A. 2023-01-19 /pmc/articles/PMC9892840/ /pubmed/36741728 http://dx.doi.org/10.3389/fonc.2022.1068994 Text en Copyright © 2023 Simonyan, Gonin, Hanks, Friedlein, Dutrec, Arokium, Rouchidane Eyitayo, Doudy, Chaignepain, Manon and Dejean https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Simonyan, Lilit
Gonin, Mathilde
Hanks, James
Friedlein, Jordan
Dutrec, Kevin
Arokium, Hubert
Rouchidane Eyitayo, Akandé
Doudy, Toukounou Megann
Chaignepain, Stéphane
Manon, Stéphen
Dejean, Laurent
Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title_full Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title_fullStr Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title_full_unstemmed Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title_short Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
title_sort non-phosphorylatable mutants of ser184 lead to incomplete activation of bax
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892840/
https://www.ncbi.nlm.nih.gov/pubmed/36741728
http://dx.doi.org/10.3389/fonc.2022.1068994
work_keys_str_mv AT simonyanlilit nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT goninmathilde nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT hanksjames nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT friedleinjordan nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT dutreckevin nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT arokiumhubert nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT rouchidaneeyitayoakande nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT doudytoukounoumegann nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT chaignepainstephane nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT manonstephen nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax
AT dejeanlaurent nonphosphorylatablemutantsofser184leadtoincompleteactivationofbax